Literature under review
“We hold 21 verified studies” is true, and on its own it undersells how much has been published. The rest of the shelf is here: 57 cannabinoid studies we know about, every one still ungraded.
Read this before the list. Every study here is still waiting for review and grading, which leaves it off the evidence ladder and out of every claim CBG Atlas publishes. A listing is simply a record that we know the study exists and have yet to assess it. It is not an endorsement, a verification or a verdict on a study’s soundness. The graded registry, with 21 studies, is the one part of the site that grades anything.
Design is not quality. The groupings follow PubMed’s publication types, and “Human trial” means only that a study was run as a trial. What it found, how large it was and whether the finding survives scrutiny are separate questions. A tier describes a study and a grade describes a claim, and this list carries tiers alone. Findings stay out as well, because a finding without a grade is exactly the unhedged claim our guardrails forbid.
Human trials (24)
PubMed classifies these as clinical trials or randomised controlled trials, a label for the design: who was studied, and how. What the trial found, and whether the result holds up, is a separate matter.
Assessing the Efficacy of Cannabinoid Compositions for Treating 3 Classes of Chronic Pain: A Real-World Evidence Study
Not graded. surfaced by the 2026-08-31 completeness audit.
Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial
Not graded. cited in prose on /cbn; cited in prose on /safety; quarantined passage — blocked pending ingest.
Safety, pharmacodynamics, and pharmacokinetics of oral cannabigerol in healthy adults
Not graded. cited in prose on /safety; quarantined passage — blocked pending ingest.
Effect of Cannabigerol on Sleep and Quality of Life in Veterans: A Decentralized, Randomized, Placebo-Controlled Trial
Not graded. quarantined passage — blocked pending ingest.
Daily Use of a Broad-Spectrum Cannabidiol Supplement Produces Detectable Concentrations of Cannabinoids in Urine Prohibited by the World Anti-Doping Agency: An Effect Amplified by Exercise
Not graded. cited in prose on /atlas; cited in prose on /cbdv; cited in prose on /consumer-products; cited in prose on /monograph; cited in prose on /safety.
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Effectiveness and Safety of Melatonin and Three Formulations of Floraworks Proprietary TruCBN™ for Improving Sleep
Not graded. cited in prose on /cbn; quarantined passage — blocked pending ingest.
Impact of Dietary Fat and Oral Delivery System on Cannabigerol Pharmacokinetics in Adults
Not graded. cited in prose on /safety.
A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality
Not graded. cited in prose on /cbn; cited in prose on /safety; quarantined passage — blocked pending ingest.
A Two-Phase, Dose-Ranging, Placebo-Controlled Study of the Safety and Preliminary Test of Acute Effects of Oral Δ-Tetrahydrocannabivarin in Healthy Participants
Not graded. cited in prose on /thcv; quarantined passage — blocked pending ingest.
The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial
Not graded. cited in prose on /cbn; quarantined passage — blocked pending ingest.
Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial
Not graded. cited in prose on /cbdv; cited in prose on /safety; quarantined passage — blocked pending ingest.
A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures
Not graded. cited in prose on /cbdv; cited in prose on /safety; quarantined passage — blocked pending ingest.
Orally administered cannabidiol does not produce false-positive tests for Δ-tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000
Not graded. surfaced by the 2026-08-31 completeness audit.
Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin
Not graded. cited in prose on /cbdv.
Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo
Not graded. cited in prose on /cbn.
Cannabidivarin for HIV-Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial
Not graded. cited in prose on /cbdv; quarantined passage — blocked pending ingest.
Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
Not graded. surfaced by the 2026-08-31 completeness audit.
Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy
Not graded. cited in prose on /cbdv.
Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration
Not graded. cited in prose on /thcv; surfaced by the 2026-08-31 completeness audit.
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
Not graded. cited in prose on /thcv; quarantined passage — blocked pending ingest.
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake
Not graded. surfaced by the 2026-08-31 completeness audit.
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
Not graded. cited in prose on /thcv.
The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers
Not graded. cited in prose on /thcv.
Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers
Not graded. cited in prose on /thcv.
Other human studies (7)
Studies in people that fall outside PubMed's trial categories: pharmacokinetics, detection and analytical work, and observational studies.
Metabolite patterns in human urine after oral administration of highly purified Δ8-THCV
Not graded. cited in prose on /thcv; quarantined passage — blocked pending ingest.
An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina
Not graded. cited in prose on /cbn; cited in prose on /safety.
CBGA ameliorates inflammation and fibrosis in nephropathy
Not graded. quarantined passage — blocked pending ingest.
In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
Not graded. quarantined passage — blocked pending ingest.
Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19
Not graded. cited in prose on /cbdv; cited in prose on /safety.
Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety
Not graded. cited in prose on /cbdv; cited in prose on /safety.
Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes
Not graded. cited in prose on /cbn.
Animal studies (21)
Studies in animals. An animal result can suggest where to look; it does not show an effect in a person.
Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice
Not graded. cited in prose on /monograph; newly published, awaiting PubMed indexing. Published 30 September 2026; PubMed had not indexed it on 12 October 2026, so it was checked against its DOI registration instead. It can be graded once PubMed lists it.
Preclinical Evidence for a Drug-Drug Interaction Between Cannabinol and Melatonin
Not graded. cited in prose on /cbn; cited in prose on /safety; quarantined passage — blocked pending ingest.
A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats
Not graded. cited in prose on /cbn.
Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol
Not graded. cited in prose on /safety.
Cannabigerolic Acid (CBGA) Inhibits the TRPM7 Ion Channel Through its Kinase Domain
Not graded. cited in prose on /cbga; quarantined passage — blocked pending ingest.
Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain
Not graded. cited in prose on /cbgv; quarantined passage — blocked pending ingest.
Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
Not graded. cited in prose on /cbga; cited in prose on /cbgv; quarantined passage — blocked pending ingest.
Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma
Not graded. cited in prose on /cbn.
Beneficial effects of the phytocannabinoid Δ-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
Not graded. cited in prose on /thcv.
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB, CBand CB/CBheteromer receptors
Not graded. cited in prose on /cbgv.
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome
Not graded. cited in prose on /cbgv.
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability
Not graded. cited in prose on /cbdv.
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
Not graded. cited in prose on /cbc.
The effect of cannabichromene on adult neural stem/progenitor cells
Not graded. cited in prose on /cbc.
The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
Not graded. cited in prose on /thcv.
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
Not graded. cited in prose on /cbc; cited in prose on /cbdv; cited in prose on /cbgv.
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease
Not graded. cited in prose on /thcv.
Δ⁹-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
Not graded. cited in prose on /thcv.
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo
Not graded. cited in prose on /thcv.
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist
Not graded. cited in prose on /thcv.
Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol
Not graded. cited in prose on /cbn.
Laboratory studies (2)
Work on cells, tissue, enzymes or chemistry. A laboratory interaction shows a mechanism; it does not show an effect in a body.
Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants
Not graded. cited in prose on /thcv.
Risk of unintentional antidoping rule violations by consumption of hemp products
Not graded. cited in prose on /cbga; cited in prose on /safety.
Reviews (3)
Summaries of other researchers' primary work. The primary evidence lives in the papers a review cites.
The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management
Not graded. cited in prose on /thcv.
Cannabinol and Sleep: Separating Fact from Fiction
Not graded. cited in prose on /cbn; cited in prose on /safety; quarantined passage — blocked pending ingest.
How a study moves to the registry
The road out runs one way. First a study is verified against its primary source; then it is graded on the six-rung ladder and added to the registry, where it appears with a rung and this list loses a row. The same road applies whether a study is interesting, recent or convenient.
56 records were verified against PubMed on 2026-08-31, and every one resolved to a live record with a DOI. One study published too recently for PubMed to list was verified against its DOI registration on 12 October 2026. Titles, authors, journals and years are copied from those records, not summarised. Registry snapshot: 2026-08-09. Nothing here is medical advice, and no statement on this page is a claim that any cannabinoid treats, cures, or prevents any condition. Report a safety event. Peregrine Biopharma funds the platform and holds no editorial authority.